PL438511A1 - Sposób jednoczesnego otrzymywania3β,7α,17β-trihydroksy-androst-5-enu i 3β,7β,17β-trihydroksy-androst-5-enu - Google Patents

Sposób jednoczesnego otrzymywania3β,7α,17β-trihydroksy-androst-5-enu i 3β,7β,17β-trihydroksy-androst-5-enu

Info

Publication number
PL438511A1
PL438511A1 PL438511A PL43851121A PL438511A1 PL 438511 A1 PL438511 A1 PL 438511A1 PL 438511 A PL438511 A PL 438511A PL 43851121 A PL43851121 A PL 43851121A PL 438511 A1 PL438511 A1 PL 438511A1
Authority
PL
Poland
Prior art keywords
androst
trihydroxy
ene
simultaneous preparation
simultaneous
Prior art date
Application number
PL438511A
Other languages
English (en)
Other versions
PL244020B1 (pl
Inventor
Paulina Łyczko
Anna Panek
Alina Świzdor
Monika Urbaniak
Łukasz Stępień
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL438511A priority Critical patent/PL244020B1/pl
Publication of PL438511A1 publication Critical patent/PL438511A1/pl
Publication of PL244020B1 publication Critical patent/PL244020B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position
    • C12P33/18—Hydroxylating at 17 position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Wynalazek dotyczy jednoczesnego sposobu otrzymywania 3β,7α, 17β-trihydroksy-androst-5-enu i 3β,7β,17β-trihydroksy-androst-5-enu, o wzorach 2 i 3, na drodze mikrobiologicznej redukcji, w której jako substrat stosuje się 7-okso-DHEA, o wzorze 1, przy użyciu systemu enzymatycznego grzyba strzępkowego Piptoporus betulinus AM39.
PL438511A 2021-07-16 2021-07-16 Sposób jednoczesnego otrzymywania 3β,7α,17β-trihydroksyandrost- 5-enu i 3β,7β,17β-trihydroksy-androst-5-enu PL244020B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL438511A PL244020B1 (pl) 2021-07-16 2021-07-16 Sposób jednoczesnego otrzymywania 3β,7α,17β-trihydroksyandrost- 5-enu i 3β,7β,17β-trihydroksy-androst-5-enu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438511A PL244020B1 (pl) 2021-07-16 2021-07-16 Sposób jednoczesnego otrzymywania 3β,7α,17β-trihydroksyandrost- 5-enu i 3β,7β,17β-trihydroksy-androst-5-enu

Publications (2)

Publication Number Publication Date
PL438511A1 true PL438511A1 (pl) 2023-01-23
PL244020B1 PL244020B1 (pl) 2023-11-20

Family

ID=84982724

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438511A PL244020B1 (pl) 2021-07-16 2021-07-16 Sposób jednoczesnego otrzymywania 3β,7α,17β-trihydroksyandrost- 5-enu i 3β,7β,17β-trihydroksy-androst-5-enu

Country Status (1)

Country Link
PL (1) PL244020B1 (pl)

Also Published As

Publication number Publication date
PL244020B1 (pl) 2023-11-20

Similar Documents

Publication Publication Date Title
BR112022010664A2 (pt) Derivados de um inibidor de fgfr
BR112021023457A2 (pt) Composto, uso do composto, composição, e, métodos para preparar a composição e um composto
BR112019018685A8 (pt) Anticorpos, composição farmacêutica, kit, usos de um anticorpo e método in vitro de identificação ou seleção de um anticorpo
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
BR112012009289A8 (pt) Método para purificar um anticorpo anti-il-13 a partir de uma mistura de amostra que compreende um anticorpo anti-il-13 e pelo menos uma proteína de célula hospedeira (hcp)
CY1116377T1 (el) Αναστολεις της ανθρωπινης πρωτεϊνικης φωσφατασης της τυροσινης και μεθοδοι χρησης
MX2023009681A (es) Composiciones de anticuerpos anti-tl1a y metodos de tratamiento en el pulmon.
BR112022027101A2 (pt) Anticorpos multiespecíficos que se ligam a bcma
CO2025006500A2 (es) Composiciones que contienen enzimas que escinden anticuerpos y métodos de uso de las mismas
PL407699A1 (pl) Sposób otrzymywania 7-O-ß-D-glukopiranozylo-5-hydroksy-4'-metoksyizoflawonu i 5-O-ß-D-glukopiranozylo-7-hydroksy-4'-metoksyizoflawonu
NZ758836A (en) Lipo-glycopeptide cleavable derivatives and uses thereof
PL438511A1 (pl) Sposób jednoczesnego otrzymywania3β,7α,17β-trihydroksy-androst-5-enu i 3β,7β,17β-trihydroksy-androst-5-enu
BR112023016539A2 (pt) Inibidores do fator xiia
BR112023005980A2 (pt) Anticorpos cd1a e seus usos
MX2008016269A (es) Fermentacion y purificacion de cromoproteinas actinomadura y especies relacionadas.
BR112023010200A2 (pt) Inibidores enzimáticos
MX2023002288A (es) Inhibidores de la secrecion de proteinas.
BR112022022620A2 (pt) Formulações de anticorpos anti-il-33
Tübel et al. Patient-specific effects of soluble factors from Staphylococcus aureus and Staphylococcus epidermidis biofilms on osteogenic differentiation of primary human osteoblasts
ZA202309302B (en) Method for treating human or animal urine by dilution and fermentation and uses of the urine obtained in particular as fertilizing substance
PL434398A1 (pl) 15α-Hydroksyoksandrolon i sposób wytwarzania 15α-hydrolsyoksandrolonu
PL429379A1 (pl) Sposób wytwarzania 19-nortestololaktonu
MX2023007309A (es) Composicion de anticuerpos.
PL418555A1 (pl) Sposób otrzymywania 7-O-β-D-glukopiranozylo-5,4'-dihydroksyflawonu